Rhythm Pharmaceuticals (RYTM) Non Operating Income (2016 - 2026)
Rhythm Pharmaceuticals (RYTM) posted quarterly Non Operating Income of -$2.7 million for Q1 2026, down 13.21% year-over-year from -$3.1 million in Q1 2025, and down 477.8% quarter-over-quarter from -$473000.0 in Q4 2025.
Rhythm Pharmaceuticals (RYTM) Non Operating Income (2016 - 2026) Analysis & Trends
Rhythm Pharmaceuticals (RYTM) has reported Non Operating Income for 11 consecutive years, with -$2.7 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Non Operating Income fell 13.21% year-over-year to -$2.7 million; the TTM figure through Mar 2026 stood at -$4.3 million (down 207.15% YoY), while the FY2025 annual figure was -$4.0 million, down 176.73% from the prior year.
- Non Operating Income declined to -$2.7 million in Q1 2026 per RYTM's latest filing, from -$473000.0 in the prior quarter.
- Across five years, Non Operating Income topped out at $8.7 million in Q2 2024 and bottomed at -$2.7 million in Q1 2026.
- Historically, Non Operating Income has averaged -$188117.6 across 5 years, with a median of -$172000.0 in 2023.
- Annual changes were most pronounced in 2022 — Non Operating Income plunged 1255.07% — and 2024, when it surged 8883.84%.
- Rhythm Pharmaceuticals' Non Operating Income stood at -$390000.0 in 2022, then soared by 55.9% to -$172000.0 in 2023, then plunged by 1136.63% to -$2.1 million in 2024, then soared by 77.76% to -$473000.0 in 2025, then slumped by 477.8% to -$2.7 million in 2026.
- Business Quant data shows RYTM's Non Operating Income at -$2.7 million in Q1 2026, -$473000.0 in Q4 2025, and -$140000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 234.30 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -139.24 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 12.40 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | -51.63 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -53.64 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Rhythm Pharmaceuticals | 7.95 Bn | 7.62 Bn | 62.32 Mn | -302,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -302,000.00 |
| Mar 31, 2026 | -2.73 Mn |
| Dec 31, 2025 | -473,000.00 |
| Sep 30, 2025 | -140,000.00 |
| Jun 30, 2025 | -999,000.00 |
| Mar 31, 2025 | -2.41 Mn |
| Dec 31, 2024 | -2.13 Mn |
| Sep 30, 2024 | -100,000.00 |
| Jun 30, 2024 | 8.70 Mn |
| Mar 31, 2024 | -1.19 Mn |
| Dec 31, 2023 | -172,000.00 |
| Sep 30, 2023 | 158,000.00 |
| Jun 30, 2023 | -99,000.00 |
| Mar 31, 2023 | 352,000.00 |
| Dec 31, 2022 | -390,000.00 |
| Sep 30, 2022 | -1.59 Mn |
| Jun 30, 2022 | 95,000.00 |
| Mar 31, 2022 | -73,000.00 |
| Dec 31, 2021 | 134,000.00 |
| Sep 30, 2021 | 138,000.00 |